Adrenergic modulation of focal adhesion kinase protects human ovarian cancer cells from anoikis
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Chronic stress is associated with hormonal changes that are known to affect multiple systems, including the immune and endocrine systems, but the effects of stress on cancer growth and progression are not fully understood. Here, we demonstrate that human ovarian cancer cells exposed to either norepinephrine or epinephrine exhibit lower levels of anoikis, the process by which cells enter apoptosis when separated from ECM and neighboring cells. In an orthotopic mouse model of human ovarian cancer, restraint stress and the associated increases in norepinephrine and epinephrine protected the tumor cells from anoikis and promoted their growth by activating focal adhesion kinase (FAK). These effects involved phosphorylation of FAKY397, which was itself associated with actin-dependent Src interaction with membrane-associated FAK. Importantly, in human ovarian cancer patients, behavioral states related to greater adrenergic activity were associated with higher levels of pFAKY397, which was in turn linked to substantially accelerated mortality. These data suggest that FAK modulation by stress hormones, especially norepinephrine and epinephrine, can contribute to tumor progression in patients with ovarian cancer and may point to potential new therapeutic targets for cancer management.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Parallel findings in animal and in vitro models support these data [11, 16–22].”
From Living Well: Protocol for a web-based program to improve quality of life in rural and urban ovarian cancer survivors (2024) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Disruption of epithelial cell-matrix interactions induces apoptosis
Frisch, S., & Francis, H. (1994) · The Journal of cell biology · doi:10.1083/jcb.124.4.619 · Cited by 3,254
Stress-induced immune dysfunction: implications for health
Glaser, R., & Kiecolt-Glaser, J. K. (2005) · Nature Reviews Immunology · doi:10.1038/nri1571 · Cited by 2,190
Discovery of a Novel, Potent, and Src Family-selective Tyrosine Kinase Inhibitor
Hanke, J. H., Gardner, J. P., Dow, R. L., Changelian, P. S., Brissette, W. H., Weringer, E. J., Pollok, B. A., & Connelly, P. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.2.695 · Cited by 1,939
Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice
llić, D., Furuta, Y., Kanazawa, S., Takeda, N., Sobue, K., Nakatsuji, N., Nomura, S., Fujimoto, J., Okada, M., Yamamoto, T., et al. (1995) · Nature · doi:10.1038/377539a0 · Cited by 1,830
pp125FAK a structurally distinctive protein-tyrosine kinase associated with focal adhesions.
Schaller, M. D., Borgman, C. A., Cobb, B. S., Vines, R. R., Reynolds, A. B., & Parsons, J. T. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.11.5192 · Cited by 1,444
Self-citationChronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma
Thaker, P. H., Han, L. Y., Kamat, A. A., Arevalo, J. M., Takahashi, R., Lu, C., Jennings, N. B., Armaiz-Pena, G., Bankson, J. A., Ravoori, M., et al. (2006) · Nature Medicine · doi:10.1038/nm1447 · Cited by 1,320
Self-citationFrisch, S. M., & Screaton, R. A. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00251-9 · Cited by 1,249
Signaling through focal adhesion kinase
Schlaepfer, D. D., Hauck, C. R., & Sieg, D. J. (1999) · Progress in Biophysics and Molecular Biology · doi:10.1016/s0079-6107(98)00052-2 · Cited by 1,175
Control of adhesion-dependent cell survival by focal adhesion kinase.
Frisch, S. M., Vuori, K., Ruoslahti, E., & Chan-Hui, P. Y. (1996) · The Journal of cell biology · doi:10.1083/jcb.134.3.793 · Cited by 1,109
McCarty, K. S., MILLER, L. S., Cox, E. B., Konrath, J. G., & McCarty, K. S. (1985) · PubMed · Cited by 1,027
Research works printed but not linked: 6
- Riley, 1979, Cancer Detect Prev., 2, 235
- Lutgendorf, 2003, Clin Cancer Res., 9, 4514
- Han, 2002, Acta Pharmacol Sin., 23, 490
- 10.1037/0278-6133.4.5.403 · doi:10.1037/0278-6133.4.5.403
- Wu, 1999, Oncol Res., 11, 461
- McCarty, 1985, Arch Pathol Lab Med., 109, 716
Cited by
Items 101–200 of 289
Mo, C., Li, J., Yang, S.-X., Guo, H., Liu, Y., Luo, X., Wang, Y., Li, J., Li, J., & Zou, Q. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01449-z · Cited by 44
Beta‐blockers exert potent anti‐tumor effects in cutaneous and uveal melanoma
Bustamante, P., Miyamoto, D., Goyeneche, A. A., Graue, P. G. D. A., Jin, E., Tsering, T., Dias, A. B. T., Burnier, M. N., & Burnier, J. V. (2019) · Cancer Medicine · doi:10.1002/cam4.2594 · Cited by 42
Norepinephrine-Induced DNA Damage in Ovarian Cancer Cells
Lamboy-Caraballo, R., Ortíz, C., Acevedo‐Santiago, A., Matta, J. L., Monteiro, Á. N. A., & Armaiz-Peña, G. N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062250 · Cited by 43
“While each adrenergic receptor sub-type (α and β) leads to different physiologic functions, the effects of adrenergic signaling in EOC have been shown to be largely mediated by β-adrenergic receptors in tumor cells, specially stimulation β2-AR [6,14,18,21,22,25].”
BackgroundNervous system regulation of the cancer genome
Cole, S. W. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.11.008 · Cited by 41
Self-citationLi, K., Zhao, G., Ao, J., Gong, D., Zhang, J., Chen, Y., Li, J., Huang, L., Xiang, R., Hu, J.-K., et al. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.09.033 · Cited by 43
Stress and catecholamines modulate the bone marrow microenvironment to promote tumorigenesis
Hanns, P., Paczulla, A., Medinger, M., Konantz, M., & Lengerke, C. (2019) · Cell Stress · doi:10.15698/cst2019.07.192 · Cited by 42
“Abbreviatons: ALL – acute lymphoblastic leukemia, AML – acute myeloid leukemia, AR – adrenergic receptor, BCL-2 – B-cell lymphoma 2, bFGF – basic fibroblast growth factor, BM – bone marrow, cAMP – cyclic adenosine monophosphate, COX2 – cyclooxygenase 2, DA – dopamine, DTC – disseminated tumor cells, EPI – epinephrine,…”
BackgroundInfluentialFiala, O., Ostašov, P., Šorejs, O., Liška, V., Büchler, T., Poprach, A., & Fínek, J. (2019) · Cancers · doi:10.3390/cancers11121856 · Cited by 40
Yang, W., Pan, L., Cheng, Y., Wu, X., Tang, B. H., Zhu, H., Zhang, M., & Zhang, Y. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109409 · Cited by 42
Lu, Y., Xu, Q., Zuo, Y., Liu, L., Liu, S., Chen, L., Wang, K., Lei, Y., Zhao, X., & Li, Y. (2017) · BMC Cancer · doi:10.1186/s12885-017-3894-0 · Cited by 39
Circulating epinephrine is not required for chronic stress to enhance metastasis
Walker, A. K., Martelli, D., Ziegler, A. I., Lambert, G. W., Phillips, S. E., Hill, S. J., McAllen, R. M., & Sloan, E. K. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.09.012 · Cited by 42
Central and peripheral nervous systems: master controllers in cancer metastasis
Shi, M., Liu, D., Yang, Z., & Guo, N. (2013) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9440-x · Cited by 43
“which was correlated with poor overall survival of the patients [133].”
BackgroundCancer Risk in the Heart Failure Population: Epidemiology, Mechanisms, and Clinical Implications
Cuomo, A., Pirozzi, F., Attanasio, U., Franco, R., Elia, F., Rosa, E. D., Russo, M., Ghigo, A., Ameri, P., Tocchetti, C. G., et al. (2020) · Current Oncology Reports · doi:10.1007/s11912-020-00990-z · Cited by 36
Benish, M., & Ben-Eliyahu, S. (2010) · Cancers · doi:10.3390/cancers2041929 · Cited by 34
“facilitated their migration, and promoted their reattachment and colonization in secondary sites [70].”
BackgroundDoi, T., Yang, J. C., Shitara, K., Naito, Y., Cheng, A., Sarashina, A., Pronk, L. C., Takeuchi, Y., & Lin, C. (2019) · Targeted Oncology · doi:10.1007/s11523-019-00620-0 · Cited by 36
Effect of chronic stress on tumorigenesis and development
Wang, C., Shen, Y., Ni, J., Hu, W., & Yang, Y. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04455-3 · Cited by 36
“In ovarian cancer, the activation of Ars by catecholamine activates FAK to inhibit the anoikis of cells [61].”
BackgroundSelf-citationTranslation of cancer immunotherapy from the bench to the bedside
Guo, Q., Huang, F., Gonçalves, C., Rincon, S. V. D., & Miller, W. H. (2019) · Advances in cancer research · doi:10.1016/bs.acr.2019.03.001 · Cited by 41
Al‐Niaimi, A., Michelson, E. L. D., Albertin, C., Karnowski, J., Niemi, C., Spencer, R. J., Shahzad, M. M. K., Uppal, S., Saha, S. A., Rice, L. W., et al. (2016) · Gynecologic Oncology · doi:10.1016/j.ygyno.2016.09.019 · Cited by 35
Self-citationBudiu, R. A., Vlad, A., Nazario, L. A., Bathula, C. S., Cooper, K. L., Edmed, J., Thaker, P. H., Urban, J. A., Kaliński, P., Lee, A. V., et al. (2016) · Cancer and Clinical Oncology · doi:10.5539/cco.v6n1p12 · Cited by 37
“Adrenergic activation has been implicated as the key mediator of these effects by modulating several growth factors, such as vascular endothelial growth factor, interleukin-6, and matrix metalloproteases (Nagaraja, Armaiz-Pena, Lutgendorf, & Sood, 2013; Sood et al., 2010).”
BackgroundBeta blockade as adjunctive breast cancer therapy: A review
Phadke, S. D., & Clamon, G. H. (2019) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2019.04.006 · Cited by 38
Hopson, M. B., Lee, S., Accordino, M. K., Trivedi, M. S., Maurer, M., Crew, K. D., Hershman, D. L., & Kalinsky, K. M. (2021) · Breast Cancer Research and Treatment · doi:10.1007/s10549-021-06210-x · Cited by 34
“In the absence of a beta blocker, norepinephrine activates cellular beta-adrenergic receptors, triggering transcription factors to regulate tumor cell proliferation and apoptosis inhibition and stimulating the migration and chemotaxis of triple negative (TN) breast cancer cells [14,15].”
BackgroundHylander, B. L., Eng, J. W. ‐., & Repasky, E. A. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-67577-0_12 · Cited by 35
“β-adrenergic signaling induces tumor cell proliferation [91, 92], invasion [93, 94], protection from anoikis [95], metastasis [94, 96, 97] and changes in the tumor microenvironment such as angiogenesis [98–100].”
BackgroundJia, Q., Zhou, Y., Song, L., Shi, X., Jiang, X. J., Tao, R., Wang, A., Wu, Y., Wei, Z., Zhang, Y., et al. (2024) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2024.01.002 · Cited by 36
“The underlying mechanism indicates that the b 2-AR-dependent activation of SRC directed FAK phosphorylation and further tumorigenesis [35,36].”
BackgroundNeuroscience in peripheral cancers: tumors hijacking nerves and neuroimmune crosstalk
Fan, H., Liang, X., & Tang, Y. (2024) · MedComm · doi:10.1002/mco2.784 · Cited by 40
“195 In pancreatic cancer cells, blocking β 2-ARs leads to G1/S phase cell cycle arrest and induces cell death.”
BackgroundNeurobiology of cancer: Adrenergic signaling and drug repurposing
Dong, Z.-K., Wang, Y., Li, W., & Jin, W. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108750 · Cited by 36
DDR1 promotes migration and invasion of breast cancer by modulating the Src-FAK signaling
Han, Q., Xiao, F., Ma, L., Zhou, J., Wang, L., Cheng, H., Zhu, J., Yao, F., Lyu, J., & Du, L. (2022) · Neoplasma · doi:10.4149/neo_2022_220316n289 · Cited by 33
Operative Trauma and Blood Loss — Impact on Tumor Growth and Recurrence
Pretzsch, E., Bösch, F., Renz, B. W., Werner, J., Angele, M. K., & Chaudry, I. H. (2020) · Shock · doi:10.1097/shk.0000000000001656 · Cited by 32
“Moreover, catecholamines may promote cell adhesion (42), mobilization, and motility (43, 44), and an increment of apoptosis- and anoikisresistance (45).”
BackgroundJordan, K. R., Hall, J., Schedin, T., Borakove, M., Xian, J. J., Dzieciątkowska, M., Lyons, T. R., Schedin, P. S., Hansen, K. C., & Borges, V. F. (2020) · Breast Cancer Research · doi:10.1186/s13058-020-01363-x · Cited by 31
Lu, Y., Zhao, H., Liu, Y., Zuo, Y., Xu, Q., Liu, L., Li, X., Zhu, H., Zhang, Y., Zhang, S., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.709057 · Cited by 34
“As indicated in some works, catecholamine’s can activate the b2-adrenergic receptors (b2-AR), thus mediating tumour cells and tumour microenvironment (5, 6).”
BackgroundNorepinephrine induces anoikis resistance in high-grade serous ovarian cancer precursor cells
Reavis, H. D., Gysler, S. M., McKenney, G. B., Knarr, M., Lusk, H. J., Rawat, P., Rendulich, H. S., Mitchell, M. A., Berger, D. S., Moon, J. S., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.170961 · Cited by 35
“To address this possibility, FTE and SKOV3 HGSC control cells were transiently prestained with CellTracker Red and pretreated with or without NE in ULA culture to enable spheroid formation.”
BackgroundInfluentialβ-blockers: a novel class of antitumor agents
Ji, Y., Chen, Xiao, X., Shan, & Kai (2012) · OncoTargets and Therapy · doi:10.2147/ott.s38403 · Cited by 36
“Furthermore, all of these effects were blocked by propranolol or the β 2 -AR-specific antagonist butoxamine.(72)”
BackgroundSalem, I., Alsalahi, M., Chervoneva, I., ABURTO, L. C., Addya, S., Ott, G. R., Ruggeri, B., Cristofanilli, M., & Fernandez, S. V. (2016) · Breast Cancer Research · doi:10.1186/s13058-016-0694-4 · Cited by 32
“FAK1 overexpression correlates negatively with patient outcome and is associated with increased cell migration, invasion, and metastasis; elevated FAK1 expression has been reported in multiple human epithelial tumors [14, 16–20].”
BackgroundGjyshi, A., Dash, S., Cen, L., Cheng, C., Zhang, C. H., Yoder, S., Teer, J. K., Armaiz-Peña, G. N., & Monteiro, Á. N. A. (2018) · Scientific Reports · doi:10.1038/s41598-018-26670-4 · Cited by 30
Sood, A. K., & Lutgendorf, S. K. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0358 · Cited by 32
“Exposure to stress concentrations of either epinephrine or norepinephrine resulted in significant inhibition of anoikis (39).”
BackgroundSelf-citationExpanding Our Therapeutic Options: Beta Blockers for Breast Cancer?
Ganz, P. A., & Cole, S. W. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.8820 · Cited by 30
Self-citationCancer neuroscience: signaling pathways and new therapeutic strategies for cancer
Zhang, S., Yuan, L., Lin, P., Yang, G., Zhou, X., Jinfu, X., Wu, M., & Huang, Y. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02364-y · Cited by 31
Dai, Z.-Y., Jin, S.-M., Luo, H., Leng, H.-L., & Fang, J.-D. (2021) · Neoplasma · doi:10.4149/neo_2021_201112n1212 · Cited by 32
Blood Vessels and Peripheral Nerves as Key Players in Cancer Progression and Therapy Resistance
Roda, N., Blandano, G., & Pelicci, P. G. (2021) · Cancers · doi:10.3390/cancers13174471 · Cited by 32
Hylander, B. L., Repasky, E. A., & Sexton, S. (2022) · Animals · doi:10.3390/ani12030371 · Cited by 30
TRAF2 Cooperates with Focal Adhesion Signaling to Regulate Cancer Cell Susceptibility to Anoikis
da Silva, S. D., Xu, B., Maschietto, M. C., Marchi, F. A., Alkailani, M. I., Bijian, K., Xiao, D., & Alaoui‐Jamali, M. A. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-1261 · Cited by 28
“Activation of FAK also protects human ovarian cancer cells from anoikis and promotes cancer progression (33, 36).”
BackgroundWang, R., Zhao, X., Yu, S., Chen, Y., Cui, H., Wu, T., Hao, C., Zhao, D., & Cheng, M. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.104092 · Cited by 28
Anti-stress effects of polyphenols: animal models and human trials
Sakakibara, H., & Shimoi, K. (2020) · Food & Function · doi:10.1039/d0fo01129k · Cited by 30
Psychological stress and cancer: new evidence of an increasingly strong link
Martinelli, R. (2020) · Translational Medicine UniSa · doi:10.37825/2239-9747.1010 · Cited by 29
“apoptosis from surrounding ECM and neighboring cells [20].”
Liu, A., Xie, H., Li, R., Ren, L., Yang, B., Dai, L., Lu, W., Liu, B., Ren, D., Zhang, X., et al. (2021) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2021.05.008 · Cited by 28
“Src has been found to interact with FAK by facilitating the phosphorylation (p) of FAK at Y397, leading to the activation of Src/FAK signaling.(28,31) However, the underlying mechanisms responsible for anoikis resistance in NSCLC cells under the regulation of Src/FAK signaling remain unclear.”
BackgroundTumor dormancy and the neuroendocrine system: an undisclosed connection?
Zappalà, G., Green, P. A., & Cole, S. W. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9400-x · Cited by 28
Self-citationAssessment of Epinephrine and Norepinephrine in Gastric Carcinoma
Mehedințeanu, A. M., Sfredel, V., Stovicek, P. O., Schenker, M., Târtea, G. C., Istrătoaie, O., Ciurea, A.-M., & Vere, C. C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042042 · Cited by 28
“This can lead to the progression of certain cancers, such as those of the ovaries, nasopharynx, or pancreas [27,28].”
BackgroundAbdin, A. A., Soliman, N. A., & Saied, E. M. (2014) · Pharmacological Reports · doi:10.1016/j.pharep.2014.07.010 · Cited by 29
Neural Regulation of Pancreatic Cancer: A Novel Target for Intervention
Chang, A., Kim-Fuchs, C., Le, C. P., Hollande, F., & Sloan, E. K. (2015) · Cancers · doi:10.3390/cancers7030838 · Cited by 30
“stress neurotransmitters and hormones [73,74,78].”
BackgroundNeural regulation of cancer: from mechanobiology to inflammation
Kim, T. P., Rowat, A. C., & Sloan, E. K. (2016) · Clinical & Translational Immunology · doi:10.1038/cti.2016.18 · Cited by 27
Dawes, R. P., Burke, K. A., Byun, D. K., Xu, Z., Stastka, P., Chan, L., Brown, E. B., & Madden, K. S. (2020) · Breast Cancer Basic and Clinical Research · doi:10.1177/1178223420931511 · Cited by 28
Spotlight on ROS and β 3-Adrenoreceptors Fighting in Cancer Cells
Calvani, M., Subbiani, A., Vignoli, M., & Favre, C. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/6346529 · Cited by 28
“β1- and β2-ARs are expressed higher in non-small-cell lung cancer [159, 160], pancreatic cancer [161, 162], breast cancer [163, 164], ovarian carcinoma [165, 166], colorectal carcinoma [167], prostate cancer [168], and melanoma [169], while β3-ARs are detected in colon and breast cancer [155, 170], vascular tumors [17…”
BackgroundMoving Beyond VEGF for Anti-angiogenesis Strategies in Gynecologic Cancer
Thanapprapasr, D., Hu, W., Sood, A. K., & Coleman, R. L. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212800626201 · Cited by 24
Self-citationRole of sympathetic nerves in the establishment of metastatic breast cancer cells in bone
Elefteriou, F. (2016) · Journal of bone oncology · doi:10.1016/j.jbo.2016.03.003 · Cited by 26
Cancer neuroscience of brain metastasis: When in Rome, do as the Romans do
Karreman, M. A., & Winkler, F. (2025) · Neuron · doi:10.1016/j.neuron.2025.08.003 · Cited by 25
Haldar, R., Berger, L. S., Rosenne, E., Radin, A. S., Eckerling, A., Sandbank, E., Sloan, E. K., Cole, S. W., & Ben‐Eliyahu, S. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.01.005 · Cited by 23
Self-citationLiu, D., Zha, L., Liu, Y., Zhao, X., Xu, X., Liu, S., Ma, W., Zheng, J., & Shi, M. (2020) · Cancer Science · doi:10.1111/cas.14676 · Cited by 23
Tumour-induced neoneurogenesis and perineural tumour growth: a mathematical approach
Lolas, G., Bianchi, A., & Syrigos, K. N. (2016) · Scientific Reports · doi:10.1038/srep20684 · Cited by 24
Does Primary Tumor Resection Induce Accelerated Metastasis in Breast Cancer? A Review
Jiao, Y., & Lv, Q. (2022) · Journal of Surgical Research · doi:10.1016/j.jss.2022.11.064 · Cited by 21
Subclinical cardiac damage in cancer patients before chemotherapy
Fabiani, I., Panichella, G., Aimo, A., Grigoratos, C., Vergaro, G., Pugliese, N. R., Taddei, S., Cardinale, D. M., Passino, C., Emdin, M., et al. (2021) · Heart Failure Reviews · doi:10.1007/s10741-021-10151-4 · Cited by 22
Dynamic interplay of neuroendocrine signaling and immuno-surveillance in tumor niche remodeling
Xu, N., Bian, S., Lyu, P., He, X., & Zheng, W. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104958 · Cited by 25
Eudaimonic well‐being and tumor norepinephrine in patients with epithelial ovarian cancer
Davis, L. Z., Slavich, G. M., Thaker, P. H., Goodheart, M. J., Bender, D., Dahmoush, L., Farley, D. M., Markon, K. E., Penedo, F. J., Lubaroff, D. M., et al. (2015) · Cancer · doi:10.1002/cncr.29516 · Cited by 23
“FAK in turn was found to be associated with poorer overall survival.(29) These findings extend prior research regarding psychosocial factors and catecholamines in the tumor microenvironment.”
BackgroundResultSelf-citationZhang, S., Lv, C., Yang, X. F., Han, Z., Zhang, S., Zhang, J., Zong, C., Gao, L., Li, L., Zhao, Q., et al. (2014) · Stem Cells and Development · doi:10.1089/scd.2014.0243 · Cited by 22
“Constraint stress might exert profound influence physically via different neuroendocrine pathways including adrenergic system and HPA axis [33,34].”
Epithelial–Mesenchymal Transition Enhances Nanoscale Actin Filament Dynamics of Ovarian Cancer Cells
Lee, S., Yang, Y., Fishman, D. A., Holl, M. M. B., & Hong, S. (2013) · The Journal of Physical Chemistry B · doi:10.1021/jp4055186 · Cited by 20
Wang, G., & Pan, S. (2025) · Annals of Surgical Oncology · doi:10.1245/s10434-025-18313-6 · Cited by 24
“42 Finally, mechanistic studies using advanced omics technologies (e.g., immunophenotyping, transcriptomics, microbiome analysis) are warranted to clarify the biological pathways through which psychosocial and nutritional interventions exert synergistic effects.”
Effects of surgical trauma and intraoperative blood loss on tumour progression
Jin, X., Han, H., & Liang, Q. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1412367 · Cited by 20
Giridhar, P. V., Funk, H. M., Gallo, C. A., Porollo, A., Mercer, C. A., Plas, D. R., & Drew, A. F. (2011) · Clinical & Experimental Metastasis · doi:10.1007/s10585-011-9420-x · Cited by 21
“Anoikis was assessed on 6-well plates precoated with poly-HEMA (Sigma) as previously described [13].”
BackgroundMethodHe, R., He, Y., Tang, Y., Zhou, H., McLeod, H. L., & Liu, J. (2015) · Pharmacogenomics · doi:10.2217/pgs.15.152 · Cited by 19
Zhong, F., Zhu, T., Pan, X., Zhang, Y., Yang, H., Wang, X., Hu, J., Han, H., Mei, L., Chen, D., et al. (2019) · Cancer Medicine · doi:10.1002/cam4.2243 · Cited by 18
Gümüşoğlu-Acar, E., Günel, T., Hosseini, M. K., Doğan, B., Tekarslan, E. E., Gürdamar, B., Çevik, N., Sezerman, O. U., Topuz, S., & Aydinli, K. (2023) · Oncology Letters · doi:10.3892/ol.2023.13728 · Cited by 18
“CI, confidence interval; miR, microRNA. matrix metalloproteinase‑associated increases in tissue invasion (57,58), VEGF‑mediated increases in angiogen‑ esis (59) and focal adhesion kinase‑mediated resistance to anoikis/apoptosis (60).”
Ragan, A. R., Leśniak, A., Bochyńska-Czyż, M., Kosson, A., Szymańska, H., Pyśniak, K., Gajewska, M. E., Lipkowski, A. W., & Sacharczuk, M. (2013) · Stress · doi:10.3109/10253890.2013.807244 · Cited by 18
“It was proposed that the breeding strategy, along with differentiation of stress-related phenomena, had altered the activity of genes coding rRNA and that this activity is important for controlling DNA repair in both lines (Antoni et al., 2006; Antonova et al., 2011; Sood et al., 2010).”
BackgroundWhy stress is BAD for cancer patients
Nagaraja, A. S., Armaiz-Peña, G. N., Lutgendorf, S. K., & Sood, A. K. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67887 · Cited by 18
Self-citationWang, Y., Wang, S., Yang, Q., Li, J., Yu, F., & Zhao, E. (2021) · Journal of Immunology Research · doi:10.1155/2021/5580672 · Cited by 29
A Comprehensive Lifestyle Randomized Clinical Trial: Design and Initial Patient Experience
Arun, B., Austin, T., Babiera, G. V., Basen‐Engquist, K., Carmack, C. L., Chaoul, A., Cohen, L. G., Connelly, L., Haddad, R., Harrison, C. A., et al. (2016) · Integrative Cancer Therapies · doi:10.1177/1534735416679516 · Cited by 19
“Sustained elevations from these pathways can result in diverse effects such as inflammation, angiogenesis, stimulation of cancer invasion, and even reduced efficacy of chemotherapy drugs.(30-32) The underlying signaling pathways(33) offer opportunities for designing new biobehavioral approaches for disrupting the effe…”
BackgroundSelf-citationRegulska, K., Regulski, M., Karolak, B., Michalak, M., Murias, M., & Stanisz, B. J. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104326 · Cited by 17
Importance of adrenergic pathways in women's cancers
Thaker, P. H., Sood, A. K., & Ramondetta, L. M. (2013) · Cancer Biomarkers · doi:10.3233/cbm-130324 · Cited by 21
“…mouse model of human ovarian cancer, restraint stress and the associated increases in NE/E protected cancer cells from anoikis and promoted their growth by activating focal adhesion kinase (FAK) which is a non-receptor tyrosine kinase that mediates physical attachment of cells to their ECM [37].”
Self-citationShin, S., Kim, K. J., Hwang, H. J., Noh, S., Oh, J. E., & Yoo, Y. C. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.722743 · Cited by 16
Chronic stress, sympathetic activation and skeletal metastasis of breast cancer cells
Elefteriou, F. (2015) · BoneKEy Reports · doi:10.1038/bonekey.2015.61 · Cited by 20
“also reported that chronic stress induced by daily restrain or ISO injections protected tumor cells from apoptosis upon loss of anchorage and detachment of the extracellular matrix in an orthotopic model of human ovarian cancer.(43) Other studies indicated that bAR stimulation increases the expression of VEGF and angi…”
BackgroundLe, C. P., Karnezis, T., Achen, M. G., Stacker, S. A., & Sloan, E. K. (2013) · Best practice & research. Clinical anaesthesiology · doi:10.1016/j.bpa.2013.10.008 · Cited by 16
“pathways [138] and protected cells against chemotherapy induced apoptosis [26, 139].”
Seiler, A., Sood, A. K., Jenewein, J., & Fagundes, C. P. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.12.013 · Cited by 16
Self-citationThe Apoptotic Resistance of BRCA1-Deficient Ovarian Cancer Cells is Mediated by cAMP
Yue, W., Ma, J., Xiao, Y., Wang, P., Gu, X., Xie, B., & Li, M. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.889656 · Cited by 19
“Recent investigations reveal that cAMP participates in promoting cancer cell proliferation, migration, invasion, and metabolism, and is a potential apoptotic suppressor (Naderi et al., 2009; Sood et al., 2010; Creed et al., 2015; Pon et al., 2016; Zhang et al., 2019).”
BackgroundPsychoneuro-oncology: How chronic stress grows cancer
Tausk, F. (2023) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2023.03.008 · Cited by 16
New challenges in psycho‐oncology: Neural regulation of the cancer genome
Cole, S. W. (2018) · Psycho-Oncology · doi:10.1002/pon.4838 · Cited by 15
Self-citationTruong, L.-L., Scott, L. J., Pal, R., Jalink, M., Gunasekera, S., & Wijeratne, D. T. (2022) · ecancermedicalscience · doi:10.3332/ecancer.2022.1430 · Cited by 15
Xie, H., Li, B., Li, L., Zou, X., Zhu, C., Li, Y., Gao, N., Chen, Q., & Li, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099179 · Cited by 17
“Sook et al found that the intratumoral catecholamine differences observed affect biological pathways involved in tumor progression such as angiogenesis, invasion, anoikis, transcription pathway activation, etc [18].”
BackgroundKoçak, M. Z., Er, M. M., Uğraklı, M., Hendem, E., Araz, M., Eryılmaz, M. K., & Artaç, M. (2023) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-023-03464-w · Cited by 14
“The anticancer effects of beta blockers have been shown in preclinical and experimental models of ovarian cancer [18], CRC [19], and angiosarcoma [20].”
BackgroundRole of CD24 in anoikis resistance of ovarian cancer cells
Li, Y., Sun, X. Y., & Wang, H. (2015) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-015-1443-0 · Cited by 14
β2-adrenoreceptor Signaling Increases Therapy Resistance in Prostate Cancer by Upregulating MCL1
Hassan, S., Pullikuth, A., Nelson, K. C., Flores, A., Karpova, Y., Baiz, D., Zhu, S., Sui, G., Huang, Y., Choi, Y. A., et al. (2020) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-1037 · Cited by 15
Fundamental Principles of Cancer Biology: Does It Have Relevance to the Perioperative Period?
Li, J., Nick, A. M., & Sood, A. K. (2015) · Current anesthesiology reports · doi:10.1007/s40140-015-0122-9 · Cited by 15
“Many different malignancies express receptors for catecholamines [62] and prostaglandins [63] exerting a direct tumoral effect, which includes promotion of tumor cell proliferation [64], adhesion [65], migration [66] and invasion [64], resistance to apoptosis and anoikis [67, 68], as well as secretion of proangiogenic…”
BackgroundSelf-citationCreekmore, A. L., Heffron, C. L., Brayfield, B. P., Roberts, P. C., & Schmelz, E. M. (2013) · Biomolecules · doi:10.3390/biom3030386 · Cited by 14
“Interestingly, Tyr-397 phosphorylation which activates FAK has been shown to increase actin bundling [35] but has also been shown to be elevated in ovarian cancer cells in response to stress, and in ovarian tumors [57].”
BackgroundHe, C., & He, J. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-024-05199-3 · Cited by 16
“…protects ovarian cancer cells from anoikis under chronic stress by activating focal adhesion kinase (FAK) through the ADRB2-Src signaling pathway [162], and induces anoikis resistance in cervical cancer cells by activating YAP1 and promoting its nuclear translocation, driving tumor growth and…”
Stress Hormones: Emerging Targets in Gynecological Cancers
Chen, G.-Q., Qiu, L., Gao, J., Wang, J., Dang, J., Li, L., Jin, Z., & Liu, X. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.699487 · Cited by 15
β2-AR inhibition enhances EGFR antibody efficacy hampering the oxidative stress response machinery
Vecchio, V. D., Mele, L. L., Panda, S. K., Sanchez-Pajares, I. R., Mosca, L., Tirino, V., Barbieri, M., Bruzzese, F., Luciano, A., Marino, F. Z., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06129-9 · Cited by 12
“The β 2-AR signaling promotes tumor initiation and progression by regulating several cell processes, such as apoptosis/anoikis [9, 10], autophagy, angiogenesis [11], in fl ammation and immune-response [12, 13], DNA damage, drug resistance and EMT [14, 15].”
Molecular mechanisms and clinical value of the correlation between depression and cancer
Chen, Y., Lu, Y.-F., Chen, S., Liu, P., He, J., Jiang, L., & Zhang, J. (2025) · Medical Oncology · doi:10.1007/s12032-025-02763-9 · Cited by 14
“Sood et al. demonstrated that norepinephrine and epinephrine activate the ADRB2-initiated FAK-mediated signaling pathway to shield ovarian cancer cells from anoikis [76].”
Integrated genomics of ovarian xenograft tumor progression and chemotherapy response
Stuckey, A. R., Fischer, A. K., Miller, D. H., Hillenmeyer, S., Kim, K. K., Ritz, A., Singh, R. K., Raphael, B. J., Brard, L., & Brodsky, A. S. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-308 · Cited by 12
“Epinephrine may be stimulating tumor growth of ovarian cancer cells, including SKOV-3 [29] and appears to be more sensitive to MT19c action than other genes in this region.”
BackgroundNew-Onset Cancer in the HF Population: Epidemiology, Pathophysiology, and Clinical Management
Cuomo, A., Paudice, F., D’Angelo, G., Perrotta, G., Carannante, A., Attanasio, U., Iengo, M., Fiore, F., Tocchetti, C. G., Mercurio, V., et al. (2021) · Current Heart Failure Reports · doi:10.1007/s11897-021-00517-y · Cited by 11
Multiple types of distress are prospectively associated with increased risk of ovarian cancer
Roberts, A. L., Ratanatharathorn, A. D., Chibnik, L. B., Kubzansky, L. D., & Tworoger, S. S. (2023) · Cancer Medicine · doi:10.1002/cam4.6125 · Cited by 12
Leptin-LepRb Expressed in Gastric Cancer Patients and Related to Cancer-Related Depression
Pan, Y., Zhou, F., He, C., Hui, L., Huang, T., & Wei, Y. (2017) · BioMed Research International · doi:10.1155/2017/6482842 · Cited by 11
“Additionally, stress promotes tumor cells resistance to apoptosis in the proinflammatory tumor microenvironment [34].”
BackgroundFAK Signaling in Rhabdomyosarcoma
Perrone, C., Pomella, S., Cassandri, M., Braghini, M. R., Pezzella, M., Locatelli, F., & Rota, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228422 · Cited by 11
“FAK activation through ADRB2-dependent activation of Src has been involved in the reduction of anoikis levels in ovarian cancer cells under adrenergic modulation [40].”
BackgroundKandil, S., Jones, S., Smith, S., Hiscox, S., & Westwell, A. D. (2020) · Molecules · doi:10.3390/molecules25153488 · Cited by 11
“Large databases such as the Cancer Genome Atlas show that FAK mRNA levels are increased in invasive breast cancers (26%) [29], and that these increased levels are correlated with poor overall patient survival [30,31].”
BackgroundThe Clinical Relevance of Beta Blockers in Ovarian Carcinoma
Hefner, J., & Csef, H. (2016) · Geburtshilfe und Frauenheilkunde · doi:10.1055/s-0042-115016 · Cited by 12
“These include studies on chemoresistance, invasivity, migration and adhesion tendency, inflammation reactions and angiogenesis [18 – 21,23 – 27,36,40].”
The Adrenergic Nerve Network in Cancer
Magnon, C. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-73119-9_15 · Cited by 10
Metadata
- Authors
- Sood, A. K., Armaiz-Pena, G. N., Halder, J., Nick, A. M., Stone, R. L., Hu, W., Carroll, A. R., Spannuth, W. A., Deavers, M. T., Allen, J. K., Han, L. Y., Kamat, A. A., Shahzad, M. M. K., McIntyre, B. W., Diaz-Montero, C. M., Jennings, N. B., Lin, Y. G., Merritt, W. M., DeGeest, K., Vivas-Mejia, P. E., Lopez-Berestein, G., Schaller, M. D., Cole, S. W., & Lutgendorf, S. K.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- University of Iowa (US)
- West Virginia University (US)
- Corresponding author
- Sood, Anil K.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2010-05-03
- Volume
- 120
- Issue
- 5
- Pages
- 1515-1523
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC2860925
- OpenAlex
- W2129041527
- Cited by
- 283
- References
- 58
- Citations by year
- 2026: 9 · 2025: 14 · 2024: 17 · 2023: 14 · 2022: 22 · 2021: 21 · 2020: 19 · 2019: 19 · 2018: 12 · 2017: 13 · 2016: 18 · 2015: 24 · 2014: 18 · 2013: 14 · 2012: 24
- FWCI
- 13.78
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (CA083639, CA101642)
- U.S. Public Health Service (A152737)
- University of Texas MD Anderson Cancer Center (CA101642)
- National Cancer Institute (CA 109298, F31CA126474, R01CA110793, CA 110793, CA 101642, CA-104825, R01CA109298, R01CA104825, R01CA140933, P50CA083639, T32CA101642)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
- Health Sciences › Medicine › Oncology › Ovarian cancer diagnosis and treatment
- Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
- Keywords
- ovarian cancer, anoikis, focal adhesion kinase, adrenergic signaling, norepinephrine, epinephrine, chronic stress, restraint stress, Src kinase, actin, tumor progression, cancer mortality, stress hormones
- MeSH terms
- Actins, Animals, Disease Models, Animal, Epinephrine, Female, Humans, Mice, Nude, Norepinephrine, Ovarian Neoplasms, Phosphorylation, Adrenergic Agents, Anoikis, Cell Line, Tumor, Cell Proliferation, Mice, Focal Adhesion Protein-Tyrosine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.